Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-002824-98Phase 4Terminated
Phase 4, randomised trial of remifentanil in acute postoperative pain (3 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Pupillary diameter (RDP). Started Aug 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-002824-98.